| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 27, 2005
From the Faculty of Medicine and Biomedical Sciences (A.K.N.), University of Yaoundé I, Cameroon; Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences (K.N.B., J.N.M.), University of Yaoundé I, Cameroon; Department of Statistical Sciences (F.G.), University of Cape Town, South Africa; Department of Cardiology (S.G.), Whipps Cross University Hospital, London, UK; and Cardiac Clinic (C.S.W.), Department of Medicine, University of Cape Town, South Africa. * To whom correspondence should be addressed. E-mail: kathleen{at}peaslake.abel.co.uk.
Background and Purpose--To determine the relationship between chronic Chlamydia pneumoniae infection and stroke in Cameroon. Methods--Sixty-four consecutive stroke patients 26 to 80 years of age were enrolled at 2 tertiary hospitals in Yaoundé, Cameroon, between March 2000 and December 2001 and matched for age and sex to 64 controls. We measured IgG (1/64) and IgA (1/16) titers against C pneumoniae in both patients and controls using a validated microimmunofluorescence technique. Results--There was no significant difference between cases and controls with respect to hypertension (P=0.2), smoking (P=0.53), alcohol intake (P=0.8), body mass index (P=0.49), waist-to-hip ratio (P=0.14), and diabetes (P=0.76). IgA antibodies were detected in 50 (78.1%) patients and 27 (42.2%) controls (odds ratio [OR] 4.29; 95% CI, 1.84 to 11.56; P=0.0002), and IgG antibodies in 41 (64.1%) patients and 35 (54.7%) controls (OR, 1.46; 95% CI, 0.68 to 3.22; P=0.29). For confirmed thrombotic stroke, the association with IgA antibodies became stronger (OR, 21.0; 95% CI, 3.38 to 868.45; P<0.0001), but there was still no association with IgG antibodies (OR, 1.86; 95% CI, 0.69 to 5.50; P=0.18). Conclusions--Our study shows a strong statistical association between (IgA, and not IgG, as a serological marker of) chronic C pneumoniae infection and stroke for the first time in a resident indigenous African population. These findings, if confirmed, may have important policy implications (in terms of antibiotic use in stroke prevention) in sub-Saharan Africa.
Revised on November 28, 2005
Accepted on December 20, 2005
Chronic Chlamydia pneumoniae Infection and Stroke in Cameroon. A Case-Control Study
Alfred K. Njamnshi;
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |